Dr Reddy's Laboratories (BOM:500124) ROE % Adjusted to Book Value : 4.54% (As of Sep. 2024)

View and export this data going back to 1992. Start your Free Trial

What is Dr Reddy's Laboratories ROE % Adjusted to Book Value?

Dr Reddy's Laboratories's ROE % for the quarter that ended in Sep. 2024 was 16.74%. Dr Reddy's Laboratories's PB Ratio for the quarter that ended in Sep. 2024 was 3.69. Dr Reddy's Laboratories's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was 4.54%.

Dr Reddy's Laboratories ROE % Adjusted to Book Value Historical Data

The historical data trend for Dr Reddy's Laboratories's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Reddy's Laboratories ROE % Adjusted to Book Value Chart

Dr Reddy's Laboratories Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

3.97

2.43

3.46

6.44

5.96

Dr Reddy's Laboratories Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															6.46	5.88	5.22	5.35	4.54

Competitive Comparison of Dr Reddy's Laboratories's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Dr Reddy's Laboratories's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dr Reddy's Laboratories's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dr Reddy's Laboratories's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Dr Reddy's Laboratories's ROE % Adjusted to Book Value falls into.

Dr Reddy's Laboratories ROE % Adjusted to Book Value Calculation

Dr Reddy's Laboratories's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	21.77%	/	3.65
	=	5.96%

Dr Reddy's Laboratories's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	16.74%	/	3.69
	=	4.54%

Dr Reddy's Laboratories ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Dr Reddy's Laboratories's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr Reddy's Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dr Reddy's Laboratories Ltd (BOM:500124) » Definitions » ROE % Adjusted to Book Value

Traded in Other Exchanges

RDY:USA DRREDDY:India RDDA:Germany RDDA:Germany R1DY34:Brazil

Address

8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034

Website

https://www.drreddys.com

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Dr Reddy's Laboratories Headlines

No Headlines